CELLDEX
Live / Applied — Third extension granted (statement of use) (as of 04 Sept 2025)
What this means for you
Not registered yet, but its 13 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97887331
- Mark type
- Stylized text
- Filed
- 13 Apr 2023
- Published for opposition
- 13 Feb 2024
- Attorney of record
- Matthew Hintz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
Owner
- CELLDEX THERAPEUTICS, INC., Hampton, NJ, US
- CELLDEX, Hampton, NJ, US
Prior registrations
Prosecution history
- 16 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Dec 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 3 GRANTED
- 04 Sept 2025 — SOU EXTENSION 3 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — AMENDMENT AFTER NOA NOT ENTERED
- 10 Jul 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 13 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2025 — SOU EXTENSION 2 GRANTED
- 08 Apr 2025 — SOU EXTENSION 2 FILED
- 12 Jun 2025 — SOU EXTENSION 1 GRANTED
- 08 Oct 2024 — SOU EXTENSION 1 FILED
- 09 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL